Translational Health Science and Technology Institute, Ncr Biotech Science Cluster, Faridabad, India.
Jawaharlal Nehru University, Delhi, India.
Expert Rev Anti Infect Ther. 2022 Nov;20(11):1401-1412. doi: 10.1080/14787210.2022.2124968. Epub 2022 Sep 21.
Antibiotics are life-saving drugs but irrational/inappropriate use leads to the emergence of antibiotic-resistant bacterial superbugs, making their treatment extremely challenging. Increasing antimicrobial resistance (AMR) among bacterial pathogens is becoming a serious public health concern globally. If ignorance persists, there would not be any antibiotics available to treat even a common bacterial infection in future.
This article intends to collate and discuss the potential of 4D's (right rug, ose, uration, and e-escalation of therapy) approach to tackle the emerging problem of AMR. For this, we searched PubMed, Google Scholar, Medline, and clinicaltrials.gov databases primarily using keywords 'optimal antibiotic therapy,' 'antimicrobial resistance,' 'higher versus lower dose antibiotic treatment,' 'shorter versus longer duration antibiotic treatment,' 'de-escalation study', and 'antimicrobial stewardship measures' and based on the findings, form and expressed our opinion.
More efforts are needed for developing diagnostics for rapid, accurate, point-of-care, and cost-effective pathogen identification and antimicrobial susceptibility testing (AST) to facilitate rational use of antibiotics. Current dosing and duration of therapies also need to be redefined to maximize their impact. Furthermore, de-escalation approaches should be developed and encouraged in the clinic. This altogether will minimize selection pressure on the pathogens and reduce emergence of AMR.
抗生素是救命药物,但不合理/不适当的使用会导致抗生素耐药细菌超级细菌的出现,使治疗变得极具挑战性。细菌病原体中的抗微生物药物耐药性(AMR)不断增加,正在成为全球严重的公共卫生问题。如果继续无视这一问题,将来甚至可能没有抗生素可以用来治疗常见的细菌感染。
本文旨在收集和讨论 4D(正确的药物、剂量、疗程和治疗降级)方法应对 AMR 新出现问题的潜力。为此,我们主要使用关键字“最佳抗生素治疗”、“抗微生物药物耐药性”、“高剂量与低剂量抗生素治疗”、“短疗程与长疗程抗生素治疗”、“降级研究”和“抗微生物药物管理措施”,在 PubMed、Google Scholar、Medline 和 clinicaltrials.gov 数据库中进行了搜索,并基于研究结果,形成并表达了我们的观点。
需要做出更多努力来开发用于快速、准确、即时、经济实惠的病原体识别和抗微生物药物敏感性测试(AST)的诊断方法,以促进抗生素的合理使用。目前的治疗剂量和疗程也需要重新定义,以最大限度地发挥其作用。此外,应该在临床上开发和鼓励降级方法。这将共同最大限度地减少对病原体的选择压力,减少 AMR 的出现。